UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~June~~April 2516, ~~2018~~2020

ENZOLYTICS, INC.

(Exact name of registrant as specified in its charter)

Delaware		333-148425		30-0808561
(state or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification Number)

~~120~~2000 WN. ~~Pomona~~Sentra ~~Avenue~~Express ~~Monrovia, CA 91016~~Way

Unit 104

Plano, Texas 75074

(address of principal executive offices) (zip code)

~~(626)~~120 ~~538-4779~~W. Pomona Avenue

Monrovia, CA 91016

(former address)

(972) 292-9414

(registrant’s telephone number, including area code)

Eco-Petroleum Solutions, Inc

(former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Emerging growth company [X]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [X]

Item 17.01 ~~Entry~~Regulation ~~into~~FD ~~a Material Definitive Agreement~~Disclosure.

On ~~June~~April 2516, ~~2018 the Company entered into a settlement agreement and stipulation (“Settlement Agreement”) with Livingston Asset Management LLC (“Livingston”) in connection with the settlement of $563~~2020,~~000~~ ~~of bona fide obligations the Company owed to certain of its creditors. The Settlement Agreement was subject to Federal court fairness hearing~~Enzolytics, ~~and on August 21, 2018 a Federal court granted approval of the Settlement Agreement~~Inc. ~~If satisfied in full~~, ~~pursuant to~~ (the ~~Settlement Agreement the~~ “Company ~~shall reduce the Company’s debt obligations in exchange for the issuance of 563,000,000 shares of Company’s common stock, in multiple tranches, pursuant to the terms of section 3(a~~”)~~(10)~~ ~~of the Securities Act of 1933, as amended. At no time may Livingston beneficially own more than 9.99% of the Company’s outstanding common stock. In connection with the transaction, the Company~~ issued ~~to Livingston~~ a ~~convertible~~press ~~promissory~~release ~~note in the principal amount of $100,000 bearing interest of 10% per year~~ to ~~cover~~update ~~legal~~shareholders ~~fees~~on ~~and other expenses, The Note is convertible into shares of~~ the ~~Company’s~~current ~~common~~corporate ~~stock at 50% of the lowest closing bid price for 10 trading days prior to the date of conversion~~initiatives. Under the terms of a separate engagement letter, in connection with the settlement agreement, the Company is to pay a registered placement agent ten percent (10%) of the dollar amount of creditor obligations extinguished pursuant to the settlement agreement

~~The~~In ~~foregoing~~accordance iswith aGeneral ~~summary~~Instruction B.2 of Form 8-K, the ~~terms~~information set forth herein and in Exhibit 99.1 hereto are deemed to be “furnished” and shall not be deemed to be “filed” for purposes of the ~~Settlement~~Exchange ~~Agreement~~Act. ~~and~~The isinformation ~~qualified~~set forth in ~~its~~Item ~~entirety~~7.01 byof ~~the~~this ~~Settlement~~Current ~~Agreement~~Report ~~attached~~on ~~hereto~~Form ~~and~~8-K ~~incorporated~~shall ~~herein~~not be deemed an admission as ~~Exhibit~~to 10the materiality of any information in this Current Report on Form 8-K that is required to be disclosed solely to satisfy the requirements of Regulation FD.1.

Safe Harbor

This release may contain certain forward-looking statements regarding our prospective performance and strategies within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations of our company, are generally identified by use of words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “project,” “seek,” “strive,” “try,” or future or conditional verbs such as “could,” “may,” “should,” “will,” “would,” or similar expressions. Our ability to predict results or the actual effects of our plans or strategies is inherently uncertain. Accordingly, actual results may differ materially from anticipated results. Some of the factors that could cause our actual results to differ from our expectations or beliefs include, without limitation, the risks discussed from time to time in our filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Except as required by applicable law or regulation, we undertake no obligation to update these forward-looking statements to reflect events or circumstances that occur after the date on which such statements were made.

Item 8.01 Other Events.

On April 16, 2020, the Company announced its new physical address and telephone number

2000 N. Sentra Express Way

Unit 104

Plano, Texas 75074

(972) 292-9414.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits: The following exhibits are filed with this report:

Exhibit No. Description

Exhibit

No.

Description

99.1

Press Release dated April 16, 2020

10.1 [SETTLEMENT AGREEMENT]

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 22, 2019
Date: April 16, 2020
		Enzolytics, Inc
	By:	/s/Harry Zhabilov
	Name:	Harry Zhabilov
	Title:	President and CEO

Filing Compare · ENZOLYTICS INC